Paris-founded company developing functional food ingredients with protein engineering and AI through its madi platform.
Protera Biosciences, Inc. develops functional ingredients for the food industry through protein engineering and artificial intelligence. Its madi platform addresses protein functionality, discovery and production efficiency, using generative AI and computational biology with precision fermentation. The company serves food manufacturers and developers in North America and Europe, and it was founded in Paris, France in 2015. Its Series A round on 11 October 2021 raised EUR 3.587 mn from investors including Grupo Bimbo SAB de CV and Sofinnova Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in